Preview

Acta Biomedica Scientifica

Advanced search

Clinical expert case of eosinophilic granulomatous vasculitis

https://doi.org/10.12737/article_59f0360ea55615.08082149

Abstract

The article is an example of individual approach to medical-social examination (MSE) of the patient with eosinophilic granulomatous with polyangiitis (EGPA) that represents the difficulty in the absence of a strictly regulated order of the criteria in systemic vasculitis. Implications of illness at the patient were presented by bronchial asthma, a bilateral hydrothorax, pericarditis, displays of polyneuropathy, and eosinophilia. Therapy by Prednisolonum of 40 mg in within a year has not allowed to achieve reduction of process activity. The hydrothorax recurred. There were signs of central nervous system impairment; the psychiatrist diagnosed organic emotional and labile disorder of vascular genesis with moderate emotional-volitional and mnestic-intellectual decrease. When conducting MSE there were difficulties at quantitative assessment of disturbances, due to the lack of EGPA in the annex to the existing order. Therefore, the decision to establish the second group of disability has been made by specialists of MSE bureau. As the patient suffers from recurrent hydrothorax, a pulmonitis, persistent obstruction of bronchi of average degree of expression, the anoxemia that is indirectly determined by depression of a saturation of oxygen to 94 %, expressed respiration dysfunction (70 %) has been established, as well as impairment of CNS and the peripheral nervous system. The forecast for convalescence is adverse. The forecast for life - rather favorable, because the heart and kidneys are not affected.

About the Authors

V. M. Karetnikova
Irkutsk State Medical Academy of Postgraduate Education - Branch Campus of the Russian Medical Academy of Continuing Professional Education
Russian Federation


I. L. Petrunko
Irkutsk State Medical Academy of Postgraduate Education - Branch Campus of the Russian Medical Academy of Continuing Professional Education
Russian Federation


References

1. Бекетова Т.В., Волков М.Ю., Насонов Е.Л. Современные подходы к диагностике и лечению эозинофильного гранулематоза с полиангиитом: международные рекомендации 2015 г. // Терапевтический архив. - 2016. - Т. 88, № 5. - С. 86-92

2. Каретникова В.М., Петрунько И.Л. Вопросы медико-социальной экспертизы при заболеваниях органов дыхания. - Иркутск: РИО ИГМАПО, 2015. -С. 63-71

3. Мэскел Н., Миллар Э. Руководство по респираторной медицине. - М.: ГЭОТАР-Медиа, 2013.-С. 571-574

4. О классификациях и критериях, используемых при осуществлении медико-социальной экспертизы граждан федеральными государственными учреждениями медико-социальной экспертизы. Приказ Министерства труда и социальной защиты РФ № 1024н от 17.12.2015 г. (с изменениями от 5.07.2016 г.)

5. Федеральные клинические рекомендации по диагностике системных васкулитов / Под ред. Е.Н. Насонова. - М., 2013. - 29 с

6. Цыбикова С.В., Страмбовкая Н.Н. Эпидемиология заболеваний периферической нервной системы по данным МУЗ ГБ БСМП, г. Улан-Удэ за 2006-2007 гг. // Бюл. ВСНЦ СО РАМН. - 2008. - № 3 (61).- С. 171-172

7. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P., French Vasculitis Study Group (FVSG). (2011). The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore), 90 (1), 19-27. doi: 10.1097/MD.0b013e318205a4c6

8. Kränke B., Aberer W. (1997). Macrolide-induced Churg - Strauss syndrome in patient with atopy. Lancet, 350, 1551-1552. doi: 10.1016/s0140-6736(05)63984-0.

9. Mahr A., Moosig F., Neumann T., Szczeklik W., Taillé C., Vaglio A. (2014) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr. Opin. Rheumatol., 26 (1), 16-23. doi: 10.1097/BOR.0000000000000015.

10. Moosig F., Bremer J.P., Hellmich B., Holle J.U., Holl-Ulrich K., Laudien M., Matthis C., Metzler C., Nölle B., Richardt G., Gross W.L. (2013). A vasculitis centre-based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis., 72 (6), 1011-1017.

11. Saech J., Owczarczyk K., Roesgen S., Hallek M., Rubbert A. (2010). Successful use of rituximab in a patient with Churg - Strauss syndrome and refractory central nervous system involvement. Ann. Rheum. Dis., 69 (6), 1254-1255.

12. Samson M., Puéchal X., Devilliers H., Ribi C., Cohen P., Stern M., Pagnoux C., Mouthon L., Guillevin L., French Vasculitis Study Group. (2013). Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg - Strauss syndrome) enrolled in two prospective trials. J. Autoimmun., 43, 60-69. doi: 10.1016/j.jaut.2013.03.003.


Review

For citations:


Karetnikova V.M., Petrunko I.L. Clinical expert case of eosinophilic granulomatous vasculitis. Acta Biomedica Scientifica. 2017;2(3):106-109. (In Russ.) https://doi.org/10.12737/article_59f0360ea55615.08082149

Views: 674


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2541-9420 (Print)
ISSN 2587-9596 (Online)